Evidence map›Paper›PMID 26929668›Full record

ArticleDrug, healthcare and patient safety2016

A fatal adverse effect of cefazolin administration: severe brain edema in a patient with multiple meningiomas.

Sirirat Tribuddharat, Thepakorn Sathitkarnmanee, Amnat Kitkhuandee, Sunchai Theerapongpakdee, Kriangsak Ngamsaengsirisup, Sarinya Chanthawong

Open access · goldAbstract readCase Reports
In one paragraph

Article in Drug, healthcare and patient safety, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Skin Complications of Orthopedic Procedures and Devices.Iranian journal of public health · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Sirirat TribuddharatDepartment of Anesthesiology, Khon Kaen University, Khon Kaen, Thailand.
Thepakorn SathitkarnmaneeDepartment of Anesthesiology, Khon Kaen University, Khon Kaen, Thailand.
Amnat KitkhuandeeDepartment of Surgery, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
Sunchai TheerapongpakdeeDepartment of Anesthesiology, Khon Kaen University, Khon Kaen, Thailand.
Kriangsak NgamsaengsirisupDepartment of Anesthesiology, Khon Kaen University, Khon Kaen, Thailand.
Sarinya ChanthawongDepartment of Anesthesiology, Khon Kaen University, Khon Kaen, Thailand.
Khon Kaen University · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cefazolin is commonly administered before surgery as a prophylactic antibiotic. Hypersensitivity to cefazolin is not uncommon, and the symptoms mostly include urticaria, skin reaction, diarrhea, vomiting, and transient neutropenia, which are rarely life threatening. We present a rare case of fatal cefazolin hypersensitivity in a female who was diagnosed with multiple meningiomas and scheduled for craniotomy and tumor removal. Immediately after cefazolin IV administration, the patient developed acute hypertensive crisis, which resolved within 10 minutes after the treatment. This was followed by unexplained metabolic acidosis. The patient then developed severe brain edema 100 minutes later. The patient had facial edema when her face was exposed for the next 30 minutes. A computed tomography scan revealed global brain edema with herniation. She was admitted to the intensive care unit for symptomatic treatment and died 10 days after surgery from multiorgan failure. The serum IgE level was very high (734 IU/mL). Single-dose administration of cefazolin for surgical prophylaxis may lead to rare, fatal adverse reaction. The warning signs are sudden, unexplained metabolic acidosis, hypertensive crisis, tachycardia, and facial angioedema predominating with or without cutaneous symptoms like urticaria.

Indexed as

adverse effectbrain edemacefazolindrug hypersensitivityhypertension

Identifiers

PMID26929668
PMCPMC4755691
OpenAlexW2258730932

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.